KHI, KidneyX, New Executive Order Create Collaborative Focus Recent data from the Centers for Disease Control and Prevention shows more than 35 million Americans are affected by kidney diseases (CKD) ... that's one in every seven adults.
The timing is right for the kidney care community to advance the treatment and potential cure of ESKD, according to a speaker here at the Southwest Nephrology Annual Conference and Cardio Renal Metabolic Annual Conference. "This is really our 'moonshot.' I've never seen anything like this in my career," John R. Sedor, MD, said. "This is our chance to work together."
As 2020 gets underway, the federal government has set its sights on bringing innovation to an area of health that affects one in seven Americans and costs the government more than NASA and the Department of Commerce combined, yet hasn't seen major innovation since the 1970s.
President Donald Trump on December 20 signed a spending bill that includes funding for federal health care agencies and $5 million to provide continued support of the KidneyX prize competition.
Dialysis technology, which continues to dominate the current treatment of end-stage renal disease patients, dates back to the early 1940s. It also typically proves unable to maintain these patients sufficiently long enough to get them to kidney transplant, which is only available for a fraction of those who need it.
KidneyX received $5,000,000 in the government spending package announced late Monday, December 16. Included as part of two "omnibus" spending packages, the Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill includes first-time funding for KidneyX for Fiscal Year 2020.
What would you do if I told you that there is an overlooked disease out there that kills more Americans per year than breast cancer and prostate cancer? Believe it or not, in the United States alone kidney disease impacts 37 million people, with 726,000 people suffering from kidney failure and in need of dialysis or a kidney transplant to live. While kidney disease affects Americans regardless of age, those over 60 are at a greater risk given the declining function of the kidney over time. There is little awareness of this health crisis and for decades we have been relying on the same treatment options.
The Kidney Innovation Accelerator, or KidneyX, a public-private partnership between the U.S. Department of Health and Human Services and the American Society of Nephrology, is heading toward the second phase of its KidneyX: Redesign Dialysis competition.
Healio.com/Nephrology is featuring each of the 15 winners of phase 1 of the KidneyX Redesign Dialysis competition. This article features Outset Medical Inc.
KidneyX and KHI are working to achieve Presidents Trump executive order, signed Wednesday, July 10, on "Advancing American Kidney Health".
